Manufacture of medical and dental instruments and supplies
Registered Address
2 plato business park, dublin 15, mulhuddart dublin ireland, 662871
Website
-
medifill limitedEstimated Valuation
€17.6m
Pomanda estimates the enterprise value of MEDIFILL LIMITED at €17.6m based on a Turnover of €14.3m and 1.23x industry multiple (adjusted for size and gross margin).
medifill limitedEstimated Valuation
€18m
Pomanda estimates the enterprise value of MEDIFILL LIMITED at €18m based on an EBITDA of €2.5m and a 7.05x industry multiple (adjusted for size and gross margin).
medifill limitedEstimated Valuation
€19.6m
Pomanda estimates the enterprise value of MEDIFILL LIMITED at €19.6m based on Net Assets of €8.8m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medifill LimitedOverview
Medifill Limited is a live company located in dublin 15, 662871 with a Companies House number of IE492741. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in December 2010, it's largest shareholder is
reb investments holdings limited
with a 100% stake. Medifill Limited is a established,
mid sized company, Pomanda has estimated its turnover at
€14.3m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Medifill Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
6 Strong
3 Regular
3 Weak
Size
annual sales of €14.3m, make it in line with the average company (€17.8m)
€14.3m - Medifill Limited
€17.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 75%, show it is growing at a faster rate (6.2%)
75% - Medifill Limited
6.2% - Industry AVG
Production
with a gross margin of 37.4%, this company has a comparable cost of product (37.4%)
37.4% - Medifill Limited
37.4% - Industry AVG
Profitability
an operating margin of 16.6% make it more profitable than the average company (6%)
16.6% - Medifill Limited
6% - Industry AVG
Employees
with 14 employees, this is below the industry average (90)
14 - Medifill Limited
90 - Industry AVG
Pay Structure
on an average salary of €49.5k, the company has an equivalent pay structure (€49.5k)
€49.5k - Medifill Limited
€49.5k - Industry AVG
Efficiency
resulting in sales per employee of €1m, this is more efficient (€179.4k)
€1m - Medifill Limited
€179.4k - Industry AVG
Debtor Days
it gets paid by customers after 144 days, this is later than average (50 days)
144 days - Medifill Limited
50 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (35 days)
0 days - Medifill Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 25 days, this is less than average (95 days)
25 days - Medifill Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 660 weeks, this is more cash available to meet short term requirements (11 weeks)
660 weeks - Medifill Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2%, this is a lower level of debt than the average (41.9%)
2% - Medifill Limited
41.9% - Industry AVG
MEDIFILL LIMITED financials
EXPORT
Medifill Limited's latest turnover from December 2023 is estimated at €14.3 million and the company has net assets of €8.8 million. According to their latest financial statements, Medifill Limited has 14 employees and maintains cash reserves of €2.3 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Turnover
14,267,825
10,726,576
2,941,250
2,673,700
6,073,738
4,259,000
3,075,384
4,323,516
Other Income Or Grants
Cost Of Sales
8,936,366
6,613,425
422,614
301,351
3,716,539
2,630,204
1,885,837
2,571,207
Gross Profit
5,331,459
4,113,151
2,518,636
2,372,349
2,357,199
1,628,796
1,189,547
1,752,309
Admin Expenses
2,960,672
2,212,388
1,615,411
1,147,264
1,181,196
969,233
962,989
-55,886
Operating Profit
2,370,787
1,900,763
903,225
1,225,085
1,176,003
659,563
226,558
1,808,195
Interest Payable
3,041
120
698
1,319
24,798
40,642
Interest Receivable
46,344
33,357
2,301
1,138
311
135
Pre-Tax Profit
2,416,757
1,933,771
903,225
1,224,965
1,177,904
660,365
226,706
1,808,263
Tax
-435,016
-348,079
13,094
-223,802
-125,469
-43,074
-361,652
Profit After Tax
1,981,741
1,585,692
916,319
1,224,965
954,102
534,896
183,632
1,446,610
Dividends Paid
30,000
Retained Profit
1,981,741
1,585,692
916,319
1,194,965
954,102
534,896
183,632
1,446,610
Employee Costs
693,352
682,705
661,124
521,311
508,370
503,456
393,018
359,990
Number Of Employees
14
14
14
11
11
11
9
9
EBITDA*
2,548,722
2,074,503
1,067,557
1,278,318
1,210,484
996,270
628,117
2,276,559
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Tangible Assets
371,181
541,731
617,092
696,612
53,448
82,078
417,975
798,873
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
371,181
541,731
617,092
696,612
53,448
82,078
417,975
798,873
Stock & work in progress
617,255
618,811
582,028
397,189
388,010
251,118
106,185
113,012
Trade Debtors
5,630,772
3,968,806
2,863,349
2,888,699
2,401,592
1,603,491
1,169,618
1,790,496
Group Debtors
29,000
29,000
Misc Debtors
45,556
210,396
207,536
179,584
50,254
74,225
94,673
43,474
Cash
2,315,516
1,803,985
1,161,084
343,734
326,793
286,821
16,521
108,014
misc current assets
total current assets
8,609,099
6,601,998
4,813,997
3,809,206
3,166,649
2,244,655
1,415,997
2,054,996
total assets
8,980,280
7,143,729
5,431,089
4,505,818
3,220,097
2,326,733
1,833,972
2,853,869
Bank overdraft
Bank loan
Trade Creditors
15,636
147,602
142,055
119,860
43,616
55,382
85,019
45,084
Group/Directors Accounts
53,000
1,300,000
other short term finances
8,598
460
7,998
6,150
4,784
7,084
2,852
2,167
hp & lease commitments
4,610
7,980
7,980
7,980
other current liabilities
157,989
179,351
50,412
65,503
47,747
87,138
44,207
35,316
total current liabilities
182,223
327,413
200,465
191,513
100,757
157,584
193,058
1,390,547
loans
hp & lease commitments
3,911
10,572
16,612
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
3,911
10,572
16,612
total liabilities
182,223
327,413
200,465
191,513
100,757
161,495
203,630
1,407,159
net assets
8,798,057
6,816,316
5,230,624
4,314,305
3,119,340
2,165,238
1,630,342
1,446,710
total shareholders funds
8,798,057
6,816,316
5,230,624
4,314,305
3,119,340
2,165,238
1,630,342
1,446,710
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Operating Activities
Operating Profit
2,370,787
1,900,763
903,225
1,225,085
1,176,003
659,563
226,558
1,808,195
Depreciation
177,935
173,740
164,332
53,233
34,481
336,707
401,559
468,364
Amortisation
Tax
-435,016
-348,079
13,094
-223,802
-125,469
-43,074
-361,652
Stock
-1,556
36,783
184,839
9,179
136,892
144,933
-6,827
113,012
Debtors
1,497,126
1,108,317
2,602
616,437
745,130
413,425
-540,679
1,833,970
Creditors
-131,966
5,547
22,195
76,244
-11,766
-29,637
39,935
45,084
Accruals and Deferred Income
-21,362
128,939
-15,091
17,756
-39,391
42,931
8,891
35,316
Deferred Taxes & Provisions
Cash flow from operations
464,808
715,810
900,314
746,702
53,503
325,737
1,181,375
48,325
Investing Activities
capital expenditure
-7,385
-98,379
-84,812
-696,397
-5,851
-810
-20,661
-1,267,237
Change in Investments
cash flow from investments
-7,385
-98,379
-84,812
-696,397
-5,851
-810
-20,661
-1,267,237
Financing Activities
Bank loans
Group/Directors Accounts
-53,000
-1,247,000
1,300,000
Other Short Term Loans
8,138
-7,538
1,848
1,366
-2,300
4,232
685
2,167
Long term loans
Hire Purchase and Lease Commitments
-4,610
-7,281
-6,661
-6,040
24,592
other long term liabilities
share issue
100
interest
46,344
30,316
-120
1,603
-181
-24,487
-40,507
cash flow from financing
54,482
22,778
1,848
-3,364
-7,978
-55,610
-1,276,842
1,286,352
cash and cash equivalents
cash
511,531
642,901
817,350
16,941
39,972
270,300
-91,493
108,014
overdraft
change in cash
511,531
642,901
817,350
16,941
39,972
270,300
-91,493
108,014
medifill limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medifill limited. Get real-time insights into medifill limited's credit score, group structure and payment trends.
Perform a competitor analysis for medifill limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in Region Area area or any other competitors across 12 key performance metrics.
medifill limited Ownership
MEDIFILL LIMITED group structure
Medifill Limited has no subsidiary companies.
Ultimate parent company
REB INVESTMENTS HOLDINGS LIMITED
#0102732
1 parent
MEDIFILL LIMITED
IE492741
MEDIFILL LIMITED Shareholders
The sole shareholder of Medifill Limited is Reb Investments Holdings Limited.
reb investments holdings limited
100%
medifill limited directors
Medifill Limited currently has 7 directors.
The longest serving directors include
ROBERT FILIK (Dec 2010) and
ANDREW RYAN (Dec 2010).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023
net assets
8.8m
+0.29%
total assets
9m
+0.26%
cash
2.3m
+0.28%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
medifill limited company details
company number
IE492741
Type
LTD - PRIVATE COMPANY LIMITED BY SHARES
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
December 2010
age
15
incorporated
IE
ultimate parent company
REB INVESTMENTS HOLDINGS LIMITED
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MCKEOGH GALLAGHER RYAN
address
2 plato business park, dublin 15, mulhuddart dublin ireland, 662871
Bank
ULSTER BANK
Legal Advisor
WALLACE CORPORATE COUNSEL LLP
medifill limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medifill limited.
medifill limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDIFILL LIMITED. This can take several minutes, an email will notify you when this has completed.
medifill limitedCompanies House Filings - See Documents
